Amgen Analyst Ratings
BenzingaMay 3 10:08 ET
Oppenheimer Reaffirms Their Buy Rating on Zimmer Biomet Holdings (ZBH)
TipRanksMay 3 08:07 ET
Oppenheimer Adjusts Price Target on Zimmer Biomet Holdings to $155 From $150
MT NewswiresMay 3 07:04 ET
Buy Rating on Zimmer Biomet Holdings: Growth Trajectory and Favorable Valuation
TipRanksMay 3 06:59 ET
Buy Rating Affirmed for Intuitive Surgical Amidst Ongoing Legal Challenges and Strong Financial Performance
TipRanksMay 3 06:49 ET
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Amgen (AMGN) and Zimmer Biomet Holdings (ZBH)
TipRanksMay 3 06:47 ET
RBC Capital Reaffirms Their Buy Rating on Amgen (AMGN)
TipRanksMay 3 06:43 ET
Morgan Stanley Adjusts Price Target on Amgen to $310 From $271, Keeps Equalweight Rating
MT NewswiresMay 3 05:43 ET
Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA) and Zimmer Biomet Holdings (ZBH)
TipRanksMay 2 13:30 ET
Zimmer Biomet Holdings Analyst Ratings
BenzingaMay 2 13:15 ET
BTIG Adjusts Price Target on Zimmer Biomet to $139 From $138, Keeps Buy Rating
MT NewswiresMay 2 11:56 ET
What 23 Analyst Ratings Have To Say About Eli Lilly and Co
BenzingaMay 1 10:01 ET
Goldman Sachs Adjusts Price Target on Eli Lilly to $740 From $723
MT NewswiresMay 1 07:35 ET
Wells Fargo Adjusts Eli Lilly Price Target to $875 From $825
MT NewswiresMay 1 07:27 ET
Morgan Stanley Raises Price Target on Eli Lilly to $1,023 From $950 Amid 2024 Guidance Boost, Keeps Overweight Rating
MT NewswiresMay 1 06:27 ET
Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Raises Price Target to $885
BenzingaApr 30 13:46 ET
Eli Lilly and Co Analyst Ratings
BenzingaApr 30 13:45 ET
Jefferies Adjusts Eli Lilly and Co.'s Price Target to $915 From $895, Keeps Buy Rating
MT NewswiresApr 30 11:54 ET
Analysts Offer Insights on Healthcare Companies: Accolade (ACCD), Vertex Pharmaceuticals (VRTX) and Zimmer Biomet Holdings (ZBH)
TipRanksApr 29 21:41 ET
Raymond James Adjusts Price Target on Danaher to $285 From $270, Keeps Outperform Rating
MT NewswiresApr 29 06:50 ET